Skip to main content

Advertisement

SpringerLink
Log in

A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Tumor necrosis factor alpha (TNF-α) is a multifunctional cytokine which plays an important role in the human immune response against various pathogens, and there may be a relationship between TNF-α 308 G/A polymorphism and cervical cancer risk. We performed a meta-analysis to get a systemic assessment of the association between TNF-α 308 G/A polymorphism and cervical cancer risk. Electronic searches of PubMed, Embase, and Web of Science were performed for all publications on the association between TNF-α 308 G/A polymorphism and cervical cancer risk through October 26, 2012. The pooled odds ratios (ORs) with their 95 % confidence interval (95 % CIs) were calculated to assess the association. Fifteen studies with a total of 3,743 cervical cancer cases and 4,096 controls were finally included into the meta-analysis. Overall, TNF-α 308 G/A polymorphism was significantly associated with increased risk of cervical cancer under three main genetic comparison models (A vs. G, OR 1.20, 95 % CI 1.02–1.42, P = 0.03; AA vs. GG, OR 1.31, 95 % CI 1.00–1.72, P = 0.048; AA vs. GG/GA, OR 1.30, 95 % CI 1.00–1.71, P = 0.05). Subgroup analysis by ethnicity further showed that there was a significant association between TNF-α 308 G/A polymorphism and increased risk of cervical cancer in Asians (AA vs. GG, OR 1.83, 95 % CI 1.05–3.20, P = 0.034; AA vs. GG/GA, OR 1.84, 95 % CI 1.05–3.22, P = 0.032). The meta-analysis suggests that TNF-α 308 G/A polymorphism is associated with increased risk of cervical cancer, and TNF-α 308 G/A mutant allele A is a risk factor of cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461–84.

    Article  PubMed  Google Scholar 

  3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907.

    Article  PubMed  CAS  Google Scholar 

  4. Thomas M, Narayan N, Pim D, Tomaic V, Massimi P, Nagasaka K, et al. Human papillomaviruses, cervical cancer and cell polarity. Oncogene. 2008;27:7018–30.

    Article  PubMed  CAS  Google Scholar 

  5. Ibeanu OA. Molecular pathogenesis of cervical cancer. Cancer Biol Ther. 2011;11:295–306.

    Article  PubMed  CAS  Google Scholar 

  6. de Freitas AC, Gurgel AP, Chagas BS, Coimbra EC, do Amaral CM. Susceptibility to cervical cancer: an overview. Gynecol Oncol. 2012;126:304–11.

    Article  PubMed  Google Scholar 

  7. Drutskaya MS, Efimov GA, Kruglov AA, Kuprash DV, Nedospasov SA. Tumor necrosis factor, lymphotoxin and cancer. IUBMB Life. 2010;62:283–9.

    Article  PubMed  CAS  Google Scholar 

  8. Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119:651–65.

    Article  PubMed  CAS  Google Scholar 

  9. Mocellin S, Nitti D. TNF and cancer: the two sides of the coin. Front Biosci. 2008;13:2774–83.

    Article  PubMed  CAS  Google Scholar 

  10. Aukrust P, Sandberg WJ, Otterdal K, Vinge LE, Gullestad L, Yndestad A, et al. Tumor necrosis factor superfamily molecules in acute coronary syndromes. Ann Med. 2011;43:90–103.

    Article  PubMed  CAS  Google Scholar 

  11. Patel R, Cafardi JM, Patel N, Sami N, Cafardi JA. Tumor necrosis factor biologics beyond psoriasis in dermatology. Expert Opin Biol Ther. 2011;11:1341–59.

    Article  PubMed  Google Scholar 

  12. Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, et al. Functional study of TNF-alpha promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw. 2011;22:88–102.

    PubMed  CAS  Google Scholar 

  13. Qidwai T, Khan F. Tumour necrosis factor gene polymorphism and disease prevalence. Scand J Immunol. 2011;74:522–47.

    Article  PubMed  CAS  Google Scholar 

  14. Wang N, Yin D, Zhang S, Wei H, Wang S, Zhang Y, et al. TNF-alpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population. PLoS One. 2012;7:e45246.

    Article  PubMed  CAS  Google Scholar 

  15. Barbisan G, Perez LO, Contreras A, Golijow CD. TNF-alpha and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol. 2012;33:1549–56.

    Article  PubMed  CAS  Google Scholar 

  16. Badano I, Stietz SM, Schurr TG, Picconi AM, Fekete D, Quintero IM, et al. Analysis of TNFalpha promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina). J Clin Virol. 2012;53:54–9.

    Article  PubMed  CAS  Google Scholar 

  17. Ivansson EL, Juko-Pecirep I, Gyllensten UB. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol. 2010;116:544–8.

    Article  PubMed  CAS  Google Scholar 

  18. Wang SS, Bratti MC, Rodriguez AC, Herrero R, Burk RD, Porras C, et al. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis. 2009;199:20–30.

    Article  PubMed  CAS  Google Scholar 

  19. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, et al. TNFalpha-308 G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol. 2007;29:249–56.

    PubMed  CAS  Google Scholar 

  20. Govan VA, Constant D, Hoffman M, Williamson AL. The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphism in south African women with cervical cancer and control women. BMC Cancer. 2006;6:24.

    Article  PubMed  Google Scholar 

  21. Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, et al. G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun. 2005;334:588–92.

    Article  PubMed  CAS  Google Scholar 

  22. Stanczuk GA, Sibanda EN, Tswana SA, Bergstrom S. Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer. Int J Gynecol Cancer. 2003;13:148–53.

    Article  PubMed  CAS  Google Scholar 

  23. Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli 2nd RL, McGovern RM, et al. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol. 2003;88:326–32.

    Article  PubMed  CAS  Google Scholar 

  24. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.

    Article  Google Scholar 

  25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  27. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, et al. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001;166:41–6.

    Article  PubMed  CAS  Google Scholar 

  28. Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, et al. Host genetic polymorphism analysis in cervical cancer. Clin Chem. 2002;48:1218–24.

    PubMed  CAS  Google Scholar 

  29. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, et al. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis. 2005;191:969–76.

    Article  PubMed  CAS  Google Scholar 

  30. Singh H, Jain M, Sachan R, Mittal B. Association of TNFα (-308 G > A) and IL-10 (-819C > T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer. 2009;19:1190–4.

    Article  PubMed  Google Scholar 

  31. Wang Q, Zhang C, Walayat S, Chen HW, Wang Y. Association between cytokine gene polymorphisms and cervical cancer in a Chinese population. Eur J Obstet Gynecol Reprod Biol. 2011;158:330–3.

    Article  PubMed  CAS  Google Scholar 

  32. Gorouhi F, Islami F, Bahrami H, Kamangar F. Tumour-necrosis factor-α polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer. 2008;98:1443–51.

    Article  PubMed  CAS  Google Scholar 

  33. Fan W, Maoqing W, Wangyang C, Fulan H, Dandan L, Jiaojiao R, et al. Relationship between the polymorphism of tumor necrosis factor-alpha-308 G > A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet. 2011;19:432–7.

    Article  PubMed  CAS  Google Scholar 

  34. Yang Y, Luo C, Feng R, Bi S. The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2011;137:947–52.

    Article  PubMed  CAS  Google Scholar 

  35. Wang J, Cao C, Luo H, Xiong S, Xu Y, Xiong W. Tumour necrosis factor alpha -308 G/A polymorphism and risk of the four most frequent cancers: a meta-analysis. Int J Immunogenet. 2011;38:311–20.

    Article  PubMed  CAS  Google Scholar 

  36. Peng WJ, He Q, Yang JX, Wang BX, Lu MM, Wang S, et al. Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk. Mol Biol Rep. 2012;39:5187–94.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, The Central Hospital of Zhumadian City, Zhumadian City, 463000, China

    Hua-Lian Zhang

  2. Department of Gynecology and Obstetrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China

    Yi-Jie Zhang

Authors
  1. Hua-Lian Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi-Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hua-Lian Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, HL., Zhang, YJ. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumor Biol. 34, 1659–1665 (2013). https://doi.org/10.1007/s13277-013-0699-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0699-x

Keywords

Search

Navigation